Currently, there are 144.44M common shares owned by the public and among those 128.36M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of 3.29% and -1.57% over the past three months. GTLB shares are trading 11.45% year to date (YTD), with the 12-month market performance down to -12.92% lower. It has a 12-month low price of $40.72 and touched a high of $76.41 over the same period. GTLB has an average intraday trading volume of 3.19 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.62%, -1.92%, and 12.93% respectively.
Institutional ownership of Gitlab Inc (NASDAQ: GTLB) shares accounts for 69.24% of the company’s 144.44M shares outstanding.
It has a market capitalization of $10.19B and a beta (3y monthly) value of 0.69. The earnings-per-share (ttm) stands at -$0.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.88% over the week and 5.44% over the month.
Earnings per share for the fiscal year are expected to decrease by -3.08%, and 32.19% over the next financial year. EPS should shrink at an annualized rate of 18.48% over the next five years, compared to 55.90% over the past 5-year period.
Looking at the support for the GTLB, a number of firms have released research notes about the stock. Macquarie stated their Outperform rating for the stock in a research note on December 12, 2024, with the firm’s price target at $90. Needham coverage for the Gitlab Inc (GTLB) stock in a research note released on October 21, 2024 offered a Buy rating with a price target of $70. Morgan Stanley was of a view on October 09, 2024 that the stock is Overweight, while BofA Securities gave the stock Buy rating on August 27, 2024, issuing a price target of $80- $66. Robert W. Baird on their part issued Outperform rating on August 27, 2024.
